Copertina

From Good to Better: Comparative Epitope Profiling Facilitates Rational Design of Effective Multi‐Epitope Vaccines Against Viruses

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Xinfeng Li, Yiyao Wang, Mingyue Zhong, Lu Liu, Heng Xue, Xia Chuai, Hongping Wei, Sandra Chiu, Hang Yang
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Journal of Medical Virology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Immunoinformatics‐Driven Design of a Multi‐Epitope Vaccine Targeting Simian Virus VP1 Major Capsid Protein for Oncogenic Viral Infection Prevention
di: Roman Akbar, et al.
Pubblicazione: (2025)

Correction to ‘Immunoinformatics‐Driven Design of a Multi‐Epitope Vaccine Targeting Simian Virus VP1 Major Capsid Protein for Oncogenic Viral Infection Prevention’
Pubblicazione: (2025)

Epitope delimitation: A new method for defining epitopes of human IgG‐reactive antigenic peptides based on rabbit‐recognized epitope motifs
di: Hai‐Ping Tang, et al.
Pubblicazione: (2024)

Large‐Scale Screening of CD4+ T‐Cell Epitopes From SARS‐CoV‐2 Proteins and the Universal Detection of SARS‐CoV‐2 Specific T Cells for Northeast Asian Population
di: Yu Zhao, et al.
Pubblicazione: (2025)

Virus‐Like Nanoparticles for Vaccine Development and Drug Delivery
di: De‐feng Li, et al.
Pubblicazione: (2026)

Maternal Vaccination and Protective Immunity Against SARS‐CoV‐2 Infection in Pups
di: Kunpeng Liu, et al.
Pubblicazione: (2025)

Correction to “Long‐Lasting Protection and Dose Optimization of MPXV Polyvalent Mpox mRNA Vaccines Against Lethal Vaccinia Virus Challenge in Mice”
Pubblicazione: (2025)

A Novel Circular Delta‐XBB.1.5 RBD Dimeric Protein Subunit Vaccine Mediated by Split Intein Elicits an Immune Response and Protection Against Multiple SARS‐CoV‐2 Variants in Mice
di: Kangyin Li, et al.
Pubblicazione: (2024)

Low Specific T‐Cell Immunity Against Mpox Elicited in People With HIV‐1 and PrEP Users After Subcutaneous Vaccination Compared to Natural Infection
di: Olivia de la Calle‐Jiménez, et al.
Pubblicazione: (2025)

Tick‐Borne Encephalitis Virus Surveillance—Vaccination‐ and Infection‐Induced Seroprevalences in Western Austria 2024
di: Anita Siller, et al.
Pubblicazione: (2024)

Landscape of Prophylactic Strategies Against Human Parainfluenza Virus Type 3
di: Clémence Vacher, et al.
Pubblicazione: (2025)

Vaccination Coverage Against Coronavirus Disease 2019 (COVID‐19) in Brazil's Indigenous Population
di: Nathália Mariana Santos Sansone, et al.
Pubblicazione: (2026)

Surveillance of Tick‐Borne Encephalitis Virus—Comparison of Vaccination‐ and Infection‐Induced Seroprevalences in Lower Bavaria, Germany
di: Philipp Girl, et al.
Pubblicazione: (2025)

ETS Translocation Variant 5 Negatively Modulates Innate Immunity to Facilitate Epstein‐Barr Virus Reactivation
di: Xuefei Liao, et al.
Pubblicazione: (2025)

Methodological Considerations in Evaluating Recombinant Zoster Vaccine Effectiveness in COPD Patients
di: Bor‐Yun Wang, et al.
Pubblicazione: (2025)

Development of Broad‐Spectrum β‐Cyclodextrins‐Based Nanomaterials Against Influenza Viruses
di: Arnaud Charles‐Antoine Zwygart, et al.
Pubblicazione: (2024)

A Herpes Simplex Virus Type‐1‐Derived Influenza Vaccine Induces Balanced Adaptive Immune Responses and Protects Mice From Lethal Influenza Virus Challenge
di: Paul J. F. Rider, et al.
Pubblicazione: (2024)

Comparative Effectiveness of High‐Dose and Standard‐Dose Influenza Vaccines for Hospitalisation and Mortality in Adults Aged 65 and Older: An Updated Systematic Review and Meta‐Analysis
di: Bilal Wazir Khan, et al.
Pubblicazione: (2026)

Antiviral Activity of the MEK1/2 Inhibitor Trametinib Against Lymphocytic Choriomeningitis Virus
di: Wenting Mao, et al.
Pubblicazione: (2025)

Epidemiology and Clinical Profile of Herpes Zoster in the Varicella Vaccine Era: A Case Series Study
di: Binshan Jiang, et al.
Pubblicazione: (2025)

Estimating the Uptake of and Factors Associated With a New Vaccine Outside of the National Immunisation Programme: A Case Study of the EV‐A71 Vaccine Against Hand, Foot, and Mouth Disease
di: Fengfeng Liu, et al.
Pubblicazione: (2025)

Dynamics of Crossed Acquired Immunity Against SARS‐CoV‐2 Variants: From Vaccine to Hybrid Immunity in China
di: Hao Wang, et al.
Pubblicazione: (2025)

Erratum to “Evaluation of the Effectiveness and Safety of Sequential Vaccination With Inactivated SARS‐CoV‐2 Vaccine and Ad5‐nCoV Booster in Pediatric Liver Transplant Recipients”
Pubblicazione: (2024)

Epidemiological Profiles of Hepatitis B Virus Genotypes Among 1–69‐year‐olds in the Mainland of China
di: Qiudong Su, et al.
Pubblicazione: (2025)

Epstein–Barr Virus Entry: An Updated Review
di: Ting Zhang, et al.
Pubblicazione: (2026)

Correction to “Modeling Antibody Kinetics Post‐mRNA Booster Vaccination and Protection Durations Against SARS‐CoV‐2 Infection”
Pubblicazione: (2025)

Vaccine‐Induced and Hybrid Immunity Against SARS‐CoV‐2 Variants of Concern in Two Cohorts in Queensland, Australia (2021–2022)
di: Rhys H. Parry, et al.
Pubblicazione: (2025)

Drug Repurposing: In Vitro Evaluation of Simeprevir as a Novel Antiviral Drug Against Severe Fever With Thrombocytopenia Syndrome Virus
di: Qian Chen, et al.
Pubblicazione: (2025)

Preventing Both EBV Infection and EBV‐Associated Diseases: Advances in Vaccine Research
di: Guo‐Long Bu, et al.
Pubblicazione: (2026)

Association of Rotavirus Infection With Biliary Atresia: A Retrospective Comparative Analysis of Virus‐Specific Antibodies
di: Yoshiki Kawamura, et al.
Pubblicazione: (2026)

Vaccination Coverage Against Coronavirus Disease 2019 in People Living on Quilombos in Brazil and Its Association With the Human Development Index and the Quality of the Health System
di: Patrícia Teixeira Costa, et al.
Pubblicazione: (2025)

Xmas‐NT: A Novel Two‐Color Fluorescence Micro Neutralization Test for the Detection of Neutralizing Antibodies Against Monkeypox Virus
di: Clemens Bodenstein, et al.
Pubblicazione: (2025)

The Effectiveness of COVID‐19 Vaccination on Post‐Acute Sequelae of SARS‐CoV‐2 Infection Among Geriatric Patients
di: Yi‐Ju Chan, et al.
Pubblicazione: (2024)

Differential Serotype Specificity in the IgG Subclass Profile of the Anti‐Domain III Response Elicited by Dengue Virus Infection
di: Luis Gabriel González‐Lodeiro, et al.
Pubblicazione: (2025)

Elderly Individuals Exhibit Elevated Levels of Anti‐Monkeypox Virus Antibodies Compared to Adults, Youth, and Children
di: Izabelle Caires Moreira dos Santos, et al.
Pubblicazione: (2024)

Seroprevalence of IgM and IgG Antibodies Directed Against Hepatitis E Virus in 4867 Blood Donors From Tyrol, Austria
di: Lisa Seekircher, et al.
Pubblicazione: (2026)

Protective Role of the Sodium Taurocholate Cotransporting Polypeptide S267F Variant Against Hepatitis B Virus Infection and Cirrhosis in the Vietnamese Population
di: Pham Xuan Huy, et al.
Pubblicazione: (2025)

Measles Resurgence: Could a Third Vaccine Dose Be the Solution?
di: Huynh Tran Bao Chau, et al.
Pubblicazione: (2026)

Proteome Profiling in Cerebrospinal Fluid Reveals Increased Levels of Peroxiredoxin 2 Discriminating Japanese Encephalitis Virus and Scrub Typhus Infection
di: Naina Soni, et al.
Pubblicazione: (2025)

Bacterial Co‐Infection Delays Hepatitis B Virus Clearance in a Chronic Replication Mouse Model by Inducing T Cell Exhaustion
di: Sumeng Li, et al.
Pubblicazione: (2025)